Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000145225 | SCV000192276 | pathogenic | Microcephaly 5, primary, autosomal recessive | 2013-02-08 | criteria provided, single submitter | clinical testing | |
3billion | RCV000145225 | SCV002573058 | pathogenic | Microcephaly 5, primary, autosomal recessive | 2022-09-01 | criteria provided, single submitter | clinical testing | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). Stop-gained (nonsense) is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported to be associated with ASPM-related disorder (ClinVar ID: VCV000157904 / PMID: 20978018). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. |
Genome- |
RCV000145225 | SCV004177563 | pathogenic | Microcephaly 5, primary, autosomal recessive | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000145225 | SCV004801270 | pathogenic | Microcephaly 5, primary, autosomal recessive | 2024-03-14 | criteria provided, single submitter | research |